HIV Treatment: Doravirine/Tenofovir/Lamivudine Study

We are studying a combination of medications for people living with HIV who have a history of specific mutations. The goal is to see if this treatment helps maintain viral control and improves health over time.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What medicines are being studied?

Medicines that are officially approved for use in the European Union and considered safe by EMA. These medicines are already on the market and may be tested for new conditions or populations.

Delstrigo
Delstrigo is a medicine used to treat HIV infection in adults by helping to control the virus.

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Doravirine
Doravirine is a substance that helps control HIV infection by preventing the virus from multiplying.
Lamivudine
Lamivudine is a substance that helps treat HIV and hepatitis B by stopping the viruses from multiplying.
Tenofovir Disoproxil
Tenofovir disoproxil is a substance that helps stop certain viruses (including HIV and hepatitis B) from multiplying in the body.

What similar medicines might you know?

Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.

Dovato
Epivir
Lamivir

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Assistance Publique Hopitaux De Paris
Infectiologie
Angers, France
Centre Hospitalier Universitaire d'Orléans
Infectiologie
Besançon, France
Centre Hospitalier Universitaire De Caen Normandie
Infectiologie
Caen, France

Sponsor: Centre Hospitalier Universitaire De Caen Normandie
Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.